Print Page

藥 物 回 收
 
Canada: Pfizer Champix Product Recall (English only)
 
Health Canada announces that Pfizer Canada ULC is recalling the following Champix (varenicline tartrate) products from retailers due to presence of impurity N-nitrosovarenicline above the acceptable concentration limit in the affected lots. The affected products are:
- Champix 0.5 mg tablets (lot number: ED7397)
- Champix 0.5/1.0 mg tablet kit (lot number: 00019062, 00020452, 00020451)

Please refer to the following website in Health Canada for details: http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/../75843r-eng.php

In Hong Kong, Champix Tab 0.5mg (HK-55479) and Champix Tab 0.5mg & 1mg (HK-55462) are pharmaceutical products registered by Pfizer Corporation Hong Kong Limited (Pfizer), and are prescription-only medicines. As confirmed with Pfizer, the affected lots have not been imported into Hong Kong.

Ends/Wednesday, Jun 16, 2021
Issued at HKT 15:00
 
Related Information:
Singapore: Recall of all batches of Champix Tablet Starter Pack and Champix Tabl... 上載於 2021-11-17
The United Kingdom: Class 2 Medicines Recall: Pfizer Ltd, Champix (all strengths... 上載於 2021-10-15
European Union: CHMP concludes assessment of presence of a nitrosamine impurity ... 上載於 2021-09-18
The United States: Pfizer Expands Voluntary Nationwide Recall to include All Lot... 上載於 2021-09-18
The United States: Pfizer expands voluntary nationwide recall to include four ad... 上載於 2021-08-17
Australia: Varenicline: TGA investigation: potential low levels of contamination... 上載於 2021-08-06
The United States: Pfizer issues a voluntary nationwide recall for twelve lots o... 上載於 2021-07-20
The United States: FDA alerts health care professionals and patients to a volunt... 上載於 2021-07-03
Canada: CHAMPIX (varenicline): Potential risk posed by long-term exposure to nit... 上載於 2021-07-02
台灣：回收戒必適膜衣錠0.5毫克 Champix (varenicline) film coated tablet 0.5 mg, 戒必適膜衣錠1毫克 Cham... 上載於 2021-07-02
 
back